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Abstract
Background: Calcifying epithelial odontogenic tumor (CEOT) is a rare benign neoplasia, locally aggressive, that
tends to invade bone and adjacent soft tissues. This case report describes the thirteenth known case of CEOT with
maxillary sinus extension and the second one that also involves the buccal vestibule mucosa with peculiar
histopathological and immunohistochemical data.
Case presentation: Here we report the case of a 45-year-old female with a CEOT diagnosed and treated at
the Oral & Maxillofacial Surgery Department, County Clinical Emergency Hospital of Craiova, Romania. The
clinical and imaging investigation revealed an intraosseous tumor developed from the left posterior maxilla
with maxillary sinus and buccal vestibule mucosa extension. Histopathology found an epithelium-rich CEOT
variant, but with scattered S100 positive clear cells, focal small rounded cementum-like deposits and areas
with some degree of nuclear pleomorphism. The immunohistochemical investigations emphasised its local
aggressiveness behavior with involvement of multiple molecular mechanisms that underlie tumor invasiveness.
A subtotal maxillectomy was performed followed by defect reconstruction.
Conclusions: We discuss the relevant clinicopathological features of an aggressive rare case of CEOT with maxillary sinus
extension and buccal vestibule mucosa involvement. The immunohistochemical study suggests its utility in attempting to
assess the degree of local tumor aggressiveness and thus in adopting the most efficient therapeutic attitude.
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Background
Calcifying epithelial odontogenic tumour (CEOT) is a
rare benign epithelial odontogenic neoplasia that is char-
acterized by the presence of amyloid-like material that
may become calcified [1].
The first cases were reported by Thoma and Goldman
[2] in 1946 as an “adenoid adamantoblastoma”, and in
1971 the term “calcifying epithelial odontogenic tumor”
was generally accepted and adopted by the WHO [3].
It is one of the least frequent odontogenic tumors, its
incidence ranging between 0.4 and 3% [4]. Although it is
a benign tumor, sometimes can be locally aggressive in-
filtrating the surrounding jaw bones structures [5, 6],
and even vital structures such as the brain [7]. Further-
more, in English literature it was reported a general re-
currence rate ranging from 15 to 30%, mostly due to
inadequate management [4, 8, 9]. On the other hand,
malignant transformation appears to be a rare event,
with less than 10 cases reported so far [10, 11].
We report here a case of intraosseous CEOT developed
from the left posterior maxilla with maxillary sinus and
buccal vestibule mucosa extension. A comprehensive im-
munohistochemical study was performed concerning the
local aggressive behavior of this tumor. A written in-
formed consent was obtained from the patient for re-
search and publication purposes.
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A 45 year old female presented to our institution with a
diffuse swelling of the left maxilla which caused a mild
tumefaction of the left cheek and obliteration of the buc-
cal vestibule, left cheek pain during chewing with auricu-
lar and temporal irradiation, and masticatory disorders.
The patient reported the onset of symptoms about
3 weeks before, but the exact duration of the swelling is
not known. However, the patient remembered that about
3 years ago she was complaining of pain in the molar re-
gion of left maxilla and she addressed to her dentist.
Without X-ray examination it was decided for extraction
of the 2nd molar which presented palatal ectopia, but
without caries and no abnormal mobility. Personal or
family records were not significant, but noteworthy is
that she worked about 10 years as an industrial dyer.
Local physical examination
Extraoral examination revealed a mild diffuse swelling of
the left cheek, most obvious at the posterior side of
the zygomatic region. It was painless and hard in
consistency on palpation. Intraoral examination revealed a
diffuse swelling extending from the maxillary left first pre-
molar to the tuberosity and retromolar regions that
obliterated the buccal vestibule (Fig. 1a). The overlying
mucosa was stretched but intact. On palpation, at the level
of maxillary alveolar process the swelling was hard and
painless but became fluctuating and slightly tender in
the retromolar region.
Radiographic and CT findings
Orthopantomogram showed a radiolucent lesion involv-
ing the left maxillary tuberosity, alveolar process, and
the maxillary sinus with erosion of lateral wall and floor
of the sinus (Fig. 1b). On computed tomography scan it
was noticed an expansile, radiolucent lesion of the left
maxilla (about 4 cm in diameter) with scattered areas of
calcification which completely obliterated the left maxil-
lary sinus (Fig. 1c). The scan showed tumor extension
and involvement of the alveolar process (behind the first
premolar with buccal cortical thinning, erosion and in-
vasion of the soft tissue from retromolar region), maxil-
lary sinus (with erosion of lateral and nasal walls, and
floor of the sinus) and palatine process.
Management
Based on history, clinical and imaging findings, a
provisional diagnosis of benign locally aggressive odonto-
genic neoplasm of the left maxilla was considered. Under
Fig. 1 Clinico-radiological and gross pathological features of the tumor. a Intraoral view of the tumor with expansion on upper left buccal
vestibule obliterations. b Orthopantomogram showing osteolytic image of left maxilla with few foci of calcifications. c Axial CT demonstrates
radiolucency of the left maxilla that completely obliterated the maxillary sinus and involvement of the alveolar process with erosion of the
cortical plate and invasion of the adjacent soft tissue. d Post-operative view of the lesion after surgical exposure. Gross features of the surgical
specimens including the alveolar process with corresponding teeth
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general anesthesia, a subtotal maxillectomy procedure was
performed through Dieffenbach’s modification of Weber–
Fergusons incision followed by defect reconstruction.
Gross examination
The surgical specimen included almost the entire left
maxilla, respectively the entire zygomatic process, the
distal alveolar process with corresponding teeth, and
limited area of the frontal and palatal processes,
measuring 4.5 × 4 × 3 cm in total (Fig. 1d). The tumor
eroded the floor and anterolateral wall of the maxil-
lary sinus, occupying the entire left maxillary sinus
being adherent to the lining mucosa but without its
ulceration. Also, this tumor distorted the left alveolar
process starting from the second bicuspid tooth up to
the retromolar area, destroying the left maxillary tu-
berosity and distal to the third molar tooth becoming
adherent to the vestibular mucosa but without its ul-
ceration. The palatal process was partially involved
but without palatal fibromucosa invasion. The tumor
itself was relatively well defined, with smooth surface
and firm in consistency. On cut section it appeared
as solid, whitish gray with various amounts of calcifi-
cation, and with sandy-like consistency.
Histopathological examination
The tumor was composed of variable amounts of poly-
hedral eosinophilic epithelial cell islands, cords and
strands in a fibrous stroma. These neoplastic cells had
well-defined boundaries, intercellular bridges in focal
areas and some degree of nuclear pleomorphism, includ-
ing few bizarre nuclei (Fig. 2a). Between cells and within
tumoral stroma, there was a conspicuous homogeneous
eosinophilic acellular material that stained positive for
Congo red (Fig. 2b). This material was confirmed as
amyloid by examination in polarized light after Congo
red staining, with the deposits exhibiting the characteris-
tically apple-green birefringence (Fig. 2c). Some of the
small round-shaped amyloid-like entities undergone
calcification and only a few of them presented Liesegang
rings. We also noticed the presence of areas with accen-
tuated nuclear pleomorphism (Fig. 2d), some multinu-
cleated giant cells (Fig. 2e), scattered S100 positive clear
cells (Fig. 2f ), and few clear cells with intracytoplasmic
PAS-positive granules (glycogen). Altogether, the tumor
did not raise the suspicion of another origin, as for
example a primary or metastatic intraosseous squamous
cell carcinoma. In some areas, between neoplastic prolifer-
ations were also observed small rounded cementum-like
deposits (Fig. 2g). The tumor proliferations penetrated the
cortical plates of maxillary bone invading the connective
tissue of the maxillary sinus mucosa and the vestibu-
lar mucosa but without involvement of the lining
epithelium (Fig. 2h, i).
Immunohistochemical findings
The polyhedral neoplastic epithelial cells were diffusely
cytoplasmic immunoreactive for CK 5/6 and CK19,
while the clear cells were negative for these epithelial
markers, exhibiting a nuclear and cytoplasmic positivity
for the anti-S100 protein. Also the tumor polyhedral
cells had an intense nuclear reactivity for p63, and with
the cytoplasm slightly positive for vimentin, but negative
for α-smooth muscle actin.
In order to explain its extremely aggressive behavior
we investigated tumor cell immunoreactivity for a num-
ber of markers related to tumor invasiveness, as listed in
Table 1. Thus, we observed expression of matrix metal-
loproteinases (MMP)-1, MMP-2, MMP-3, and MMP-9
mainly in the nuclei of tumor cells, while for MMP-3
and MMP-9 the immunoreactivity was also present in
the cytoplasm of tumor cells and in the amyloid deposits
(Fig. 3a, b). In addition, collagen IV reactivity was detected
as a linear pattern around the tumor islands, sheets and
nests but with variable thickness along the tumor tissue
with discontinuities at the advancing edge (Fig. 3c).
Investigation of markers involved in cell adhesion showed
a positive reaction with prevailing membranous pattern in
the tumor cells for E-, N- and P-cadherin, Integrin β1 and
Beta-catenin. However, as a peculiarity of the tumor advan-
cing edge, where small groups or cords of infiltrating tumor
cells were present, the staining pattern became also cyto-
plasmic for all cadherins, Integrin β1 and Beta-catenin
(Fig. 3d), and even nuclear for N- (Fig. 3e) and P-cadherin.
In these areas the membranous immunoreactivity de-
creased and at least for E-cadherin we noticed an increased
cytoplasmic colocalization with vimentin (Fig. 3f).
Investigation of other markers involved in the epithelial-
mesenchymal transition process revealed mostly a nuclear
reactivity of tumor cells for Twist 1 and Slug 1 (Fig. 3g)
that seemed to be more intense at the advancing edge.
Also, the chemokine receptor −4 (CXCR4) reactivity was
also noticed in tumor cells with membranous, cytoplasmic
and even nuclear pattern (Fig. 3h) Moreover, the podopla-
nin tumor cell reactivity, with a membranous pattern, was
more obvious at the advancing edge, at the periphery of
tumor proliferations (Fig. 3i). However the Ki-67 labeling
index in tumor cells was less than 3% and without any sig-
nificant difference regarding the tumor topography.
A final diagnosis of intraosseous CEOT with maxillary
sinus and buccal vestibule submucosa extension was
made on the basis of the above findings. After 12 months
of follow-up, the patient did not present any clinical or
radiographic evidences of recurrence.
Discussion
CEOT is a rare benign odontogenic neoplasm of epithelial
origin with locally aggressive behavior that so far does not
exceed 200 reported cases [10]. In our experience this is
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the second case of CEOT from a total of 231 cases of
odontogenic tumours diagnosed in our hospital since
1990. The general epidemiological profile reported in the
literature for this odontogenic tumor shows a mean age at
presentation of 40 years, with no gender predilection and
mandible as the most commonly affected jaw bone [1].
Similarly to other authors [4], our results indicated the
intermediary layer of the enamel organ as the most prob-
able origin for this type of odontogenic tumor.
One of the peculiarities of the presented case is its
intraosseous development in the left posterior maxilla
with extraosseous involvement of maxillary sinus and
buccal vestibule mucosa. Reviewing the literature, we
found other 12 cases of CEOT with an extension to the
maxillary sinus, which are summarized in Table 2. Thus,
the present case is the thirteenth CEOT with maxillary
sinus extension and the second one that also involved
the buccal vestibule mucosa. These aggressive CEOT tu-
mors seem to develop at a median age of 35 years with
no gender predilection, in association or not with im-
pacted teeth and no predilection for the right or left
maxilla [4, 12–22]. Histopatologically they had the same
features as a conventional COET, only one case being
reported with the clear cell variant and another one with
the cystic variant. A particular feature of the present
case was the presence of scattered S100+ clear cells and
deposits of cementum-like material. In more than half of
these cases, CEOT evolved extraosseous with extension
Fig. 2 The main histomorphological features of the tumor. a The tumor was composed of polyhedral neoplastic cells with intercellular bridges
and some degree of nuclear pleomorphism (hematoxylin and eosin [H&E]; original magnification × 40). b Homogeneous eosinophilic acellular
material between neoplastic proliferations that stained positive for Congo red (Congo red stain; original magnification × 40). c Intercellular deposits
with apple-green birefringence on polarized light examination of the Congo red stained sample (original magnification × 40). d Tumor areas with
nuclear pleomorphism (H&E; original magnification × 40). e Tumor areas with nuclear pleomorphism and multinucleate giant cells (H&E;
original magnification × 40). f Scattered S100 positive clear cells between polyhedral neoplastic cells (immunostaining, original magnification
× 20). g Tumor comprises areas with cementum-like material (*) (H&E; original magnification × 10). h Tumor invasion of the maxillary sinus mucosa
without involvement of the lining epithelium (H&E; original magnification × 10). i Tumor invasion of vestibular mucosa without involvement of the
lining epithelium (H&E; original magnification × 10)
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in the adjacent soft tissues, and to the neighboring
natural cavities (oral cavity, orbit, nasal fossae, and eth-
moidal air cells) [4, 12–22].
It is well know that this odontogenic tumor can be lo-
cally aggressive, and exhibit up to 15% recurrence rates,
especially in cases treated by conservative techniques [9].
Throughout time several prognostic factor have been
proposed to predict the behavior of such tumors and to
estimate their recurrence risk. Thereby, clinical features
such as size, anatomic site, and health status of the pa-
tient have been shown to influence prognosis of these
tumors [4, 12]. It is widely accepted that maxillary
CEOTs tend to be more aggressive and involve much
easier the surrounding vital structures than mandibular
tumors. As it is also mentioned in the literature, and as
well as in our case, amyloid deposits were not very
abundant, with calcifications being even less present, a
fact that might suggest a more aggressive behavior [23].
Also, CEOTs with clear cells seem to be more aggres-
sive, with a higher rate of recurrence (22%) and frequently
associated with cortical bones perforation [24]. In the
present case we showed that few S100+ cells were scat-
tered between eosinophilic polygonal neoplastic cells. This
reactivity reflects the dendritic nature of these cells and
their clear cell morphology could be an effect of tumor
microenvironment on the Langerhans cells migrating in
the tumor as a result of the host’s immune response [25].
Such morphological changes could represent a mechan-
ism by which tumours can escape immune surveillance
and gain a more aggressive biologic behavior.
For a better understanding of the molecular mechanisms
that underlie the aggressiveness of this odontogenic tumor
we planned to investigate the expression patterns of a num-
ber of markers known to be involved in tumor invasiveness.
First we have checked the tumor cells reactivity for the
main MMPs (MMP-1, −2, −3, −4) known to be involved
in extracellular matrix remodeling. Thus we noticed a
tumor nuclear reactivity for all MMPs but with high in-
tensity especially for MMP-3 and MMP-9, which were
also expressed in the cytoplasm and within amyloid
deposits. Henriques et al. [26] found a higher MMP9 ex-
pression both in tumor cells and stroma, for keratocystic
odontogenic tumors and ameloblastomas, that might
justify their locally aggressive behavior. The nuclear
tumor cell expression for the all 4 investigated MMPs
reported by us might also be linked to new functional
Table 1 Characteristics of the antibodies utilised in the study
Antibody name Clone Company Dilution Staining pattern
MMP1 3B6 Santa Cruz Biotechnology, Inc. Dallas, USA 1:25 Nuclear
MMP2 2C1 Santa Cruz Biotechnology 1:25 Nuclear
MMP3 1B4 Santa Cruz Biotechnology 1:25 Nuclear, cytoplasmic,
amyloid
MMP9 2C3 Santa Cruz Biotechnology 1:25 Nuclear, cytoplasmic,
amyloid
E-cadherin NCH-38 Dako, Glostrup Denmark 1:30 Membranous, cytoplasmic
N-cadherin 6G11 Dako 1:30 Membranous, nuclear
P- cadherin H-105 Santa Cruz Biotechnology 1:30 Membranous, cytoplasmic, nuclear
Integrin β1 4B7R Santa Cruz Biotechnology 1:30 Membranous (lost in some areas), cytoplasmic
Beta-catenin β-catenin-1 Dako 1:100 Membranous, cytoplasmic
Vimentin SP20 Thermo Fisher Scientific, Waltham, USA 1:200 Cytoplasmic
Twist 1 10E4E6 Leica Biosystems, Wetzlar, Germany 1:1000 Nuclear
Slug 1 1A6 Novus Biologicals, Abingdon, UK 1:50 Nuclear, cytoplasmic
CXCR4 polyclonal Thermo Scientific 1:500 Membranous, cytoplasmic, nuclear
Podoplanin D2-40 Dako 1:50 Membranous
Collagen IV CIV 22 Dako 1:50 Basement membranes
Ki-67 MIB-1 Dako 1:50 Nuclear
Cytokeratin 5/6 D5/16 B4 Dako 1:50 Cytoplasmic
Cytokeratin19 b170 Leica Biosystems 1:150 Cytoplasmic
P63 7JUL Leica Biosystems 1:25 Nuclear
S100 polyclonal Dako 1:500 Cytoplasmic, nuclear
Actin (Smooth Muscle 1A4 Dako 1:40 Cytoplasmic
Actin, Smooth Muscle polyclonal Thermo Scientific 1:100 Cytoplasmic
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roles, such as activation of some cancer-related signaling
pathways that could promote tumor proliferation, and
most likely invasion and metastasis [27]. Moreover,
studying the collagen IV expression, we noticed absence
or discontinuity in reactivity at the invasion front, a fact
that could justify the local aggressiveness of the pre-
sented case. Other studies pointed out that collagen IV
expression could be correlated with the growth and ag-
gressiveness of odontogenic tumors [26, 28]. Thus
MMP-9 and collagen IV could be useful markers in
assessing the degree of local aggressiveness of these
odontogenic tumors, including the CEOTs.
Investigating the epithelial–mesenchymal transition
(EMT) process, we have found that tumor cells were
reactive for all investigated cadherins, for Integrin β1
and Beta-catenin with a gradual transition from the
membranous pattern to a cytoplasmic pattern toward
the advancing edge. In addition, we have observed even
a nuclear reactivity for N- and P-cadherin. Moreover, as
a sign of active EMT, we found an increased cytoplasmic
reactivity for vimentin and a prevailing nuclear Twist 1
and Slug 1 expression in tumor cells, especially at the
tumor’s advancing edge. Our results were confirmed in
the literature by cases of ameloblastomas, where it was
also been noticed an E-cadherin downregulation simul-
taneously with an upregulation of podoplanin, β-catenin,
and CD44v6 at the tumor advancing edges, suggesting
their involvement in mediating collective cell migration
Fig. 3 Immunohistochemical patterns of the tumor. a–b Neoplastic epithelial cells with strong nuclear and cytoplasmic staining for MMP-3 and
MMP-9 (immunostaining, original magnification × 20). c Variable collagen IV reactivity around neoplastic epithelial proliferations (immunostaining,
original magnification × 20). d Neoplastic epithelial cells from tumor advancing edge with strong membrane and cytoplasmic staining for Beta-catenin
(immunostaining, original magnification × 20), e Neoplastic epithelial cells from tumor advancing edge with strong membrane and nuclear staining for
N-cadherin (immunostaining, original magnification × 20). f Neoplastic epithelial cells from tumor advancing edge with E-cadherin (brown staining)
and vimentin (red staining) cytoplasmic colocalization (double immunostaining, original magnification × 20). g Neoplastic epithelial cells from tumor
advancing edge with strong cytoplasmic and nuclear reactivity for Slug 1 (immunostaining, original magnification × 20). h Neoplastic epithelial cells
with strong membrane, cytoplasmic and nuclear reactivity for CXCR4 (double immunohistochemical detection CXCR4-brown staining and
vimentin- red staining) (double immunostaining, original magnification × 20). i Podoplanin tumor cell reactivity, with a membranous pattern at
the advancing edge, mainly at the periphery of tumor proliferations (immunostaining, original magnification × 10)
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Table 2 Clinicopathological features of currently reported cases of CEOT involving the maxillary sinus
Reference Age Gender Teeth involvement Maxillary bone involved Extraosseous extension besides maxillary sinus Microscopic features Follow up
Gon, 1965 [14] 35 Female First molar Right maxilla No Conventional NP
Stimson et al., 1968 [19] 35 Male Third molar Left maxilla Left nasal fossa NF NF
Lee et al., 1992 [16] 27 Female Second premolar Left maxilla No Conventional 7 years.
Bridle et al., 2006 [12] 30 Female Displacement of the second
premolar and first molar
Right maxilla Displacement of the eye globe Conventional NP
Gopalakrishnan et al.,
2006 [15]
15 Male Second molar Left maxilla Nasal cavity, narrowing and compressing
the inferior meatus
Cystic variant 1 year
Mohtasham et al.,
2008 [17]
18 Male No Right maxilla None Conventional NP
da Rosa et al., 2011 [13] 33 Female No Left maxilla Lateral wall of nasal cavity, soft tissue,
masseter, orbicularis oris, medial pterygoid
Conventional NP
Sahni et al., 2012 [4] 52 Male No Right maxilla No Conventional and clear cell 3 years
Müller et al., 2012 [18] 36 Male No Right maxilla No Conventional 4 years
Carrero et al., 2014 [20] 69 Male Third molar Left maxilla No Conventional 8 years
Foroughi et al., 2015 [21] 34 Female No Recurrence in
left maxilla
Orbit and ethmoidal air cells superiorly
and the nasal airway medially
Conventional 8 years
Rani et al., 2016 [22] 48 Female No Right maxilla Connective tissue of oral mucosal Conventional 1 year
Present case 45 Female Palatal ectopia of the
second molar
Left maxilla Buccal vestibule mucosa Conventional with few clear cells
and cementum-like components
0.6 years












and local invasiveness [29]. Moreover, it has been reported
that transcription factors such as Snail, Slug, SIP1, and
Twist could have differential roles in mediating local inva-
siveness in ameloblastomas [30]. Also, in the present study
we have observed a podoplanin expression at the advan-
cing edge, mainly at the periphery of tumor proliferations,
suggesting its involvement in tumor invasiveness. In fact,
it is well known that this transmembrane sialomucin is in-
volved in odontogenesis and in promoting local invasion
of various odontogenic tumors [29].
A series of studies reported the role of CXCR4 in
modulation of cancer cells migration in several human
malignancies, especially due to increase production of
MMPs [31, 32]. Here we have observed membrane and
nuclear CXCR4 reactivity in CEOT cells regardless of
tumor topography (tumor center versus the advancing
edge), suggesting the involvement of this chemokine in
mediating locally tumor cell invasion or even a potential
malignant evolution of this tumor.
However, despite its aggressive behavior, we found that
less than 3% of tumor cells were positive to Ki-67, a
value that falls within the range (0.27–10%) reported by
the literature for this kind of tumors [33]. Higher values
were recorded in CEOTs with malignant transformation,
with at least three-fold increase in the suspected malig-
nant area compared to benign areas [11]. A reduced
level of Ki-67 index together with the absence of any
clinical finding of metastasis, with no vascular invasion
or atypical mitotic figures, justifies the benign character
of the tumor in the current case.
Summarizing our results we can conclude that the pecu-
liar locally aggressive behavior of the presented case is the
result of the involvement of multiple molecular mecha-
nisms. Thus investigating such biomarkers could be useful
in assessing the degree of local aggressiveness and even the
malignant potential of these odontogenic tumors, suggest-
ing also the most efficient type of therapeutical approach.
Conclusions
This case report describes the thirteenth known case of
CEOT with maxillary sinus extension and the second one
that also involves the buccal vestibule mucosa. Histopatho-
logically, this case corresponds to an epithelium-rich
CEOT variant, but with scattered S100+ clear cells and de-
posits of cementum-like material. The immunohistochemi-
cal investigation confirms its aggressive behavior by tumor
overexpression of biomarkers involved especially in extra-
cellular matrix degradation, cell adhesion and the EMT
processes, and even a potential malignant evolution of this
tumor. However, our case did not fulfill the other criteria
of malignancy thus was deemed a benign tumor. A radical
surgery resection with defect reconstruction was per-
formed and after 12 months following the treatment there
was no signs of recurrence.
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